Brandywine Managers’s Avidity Biosciences RNAM Stock Holding History

Brandywine Managers’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,540	Closed	-$905K	–	42
2025 Q4	$905K	Hold	12,540	–	–	0.45%	21
2025 Q3	$546K	Buy	+12,540	New	+$507K	0.52%	24

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Brandywine Managers's RNAM Position: Q1 2026 in Review

Brandywine Managers sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 12,540 shares — an estimated $905K sold.

Brandywine Managers first reported a position in RNAM in Q3 2025 and held it in 2 quarters. The position peaked at $905K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Brandywine Managers reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Brandywine Managers sold 12,540 Avidity Biosciences shares in Q1 2026, an estimated $905K.
Brandywine Managers first reported a position in Avidity Biosciences in Q3 2025 and held it in 2 quarters.
Brandywine Managers's Avidity Biosciences position peaked at $905K in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Brandywine Managers's 13F filing for Q1 2026, filed 14 May 2026.